LON:IDP

InnovaDerma (IDP) Share Forecast, Price & News

GBX 29

+1.00 (+3.57%)

(As of 05/20/2022 12:00 AM ET)

Add

Compare

Today's Range: 28
▼
29
50-Day Range: 25
▼
33.01
52-Week Range: 25
▼
45.50

Volume: 15,000 shs
Average Volume: 112,285 shs
Market Capitalization: £8.14 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive IDP News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovaDerma and its competitors with MarketBeat's FREE daily newsletter.

About InnovaDerma

InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in the United Kingdom, the United States, Australasia, and the Asia Pacific region. The company offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee brand name; and hair removal wax and jelly, and shave and shower sorbet under the Nuthing brand. It also provides tanning mousses, tanning gels, tanning oils, primers, moisturizers, and applicators under the Skinny Tan brand name; Prolong, a Class II medical device for the treatment of premature ejaculation; haircare products comprising shampoos, conditioners, and spray treatment for men and women to aid hair regrowth and hair thickening under the Roots brand name; and hair growth products under the GrowLase brand. The company sells its products through online and DTC channels. InnovaDerma PLC was incorporated in 2014 and is headquartered in London, the United Kingdom.

April 1, 2022 | lse.co.uk

LONDON MARKET MIDDAY: Stocks struggle despite M&A impetus

December 20, 2021 | lse.co.uk

SMALL-CAP WINNERS & LOSERS: Innovaderma surges on optimistic prospects

October 14, 2021 | lse.co.uk

InnovaDerma ropes in Love Island star as 'Skinny Tan' ambassador

September 8, 2021 | lse.co.uk

DIRECTOR DEALINGS: IntegraFin founder sells for charitable purposes

September 3, 2021 | lse.co.uk

UPDATE 3-Oil rises on declining inventories and weaker dollar

September 3, 2021 | lse.co.uk

Barloworld sees "no benefit" of maintaining its listing in London

July 9, 2021 | lse.co.uk

Lyx Msci Usa Regulatory News

May 3, 2021 | finance.yahoo.com

Read This Before Selling InnovaDerma PLC (LON:IDP) Shares

April 19, 2021 | lse.co.uk

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

March 19, 2021 | in.finance.yahoo.com

InnovaDerma PLC (IDP.L)

November 1, 2020 | finance.yahoo.com

Trade Alert: The Independent Non-Executive Director Of InnovaDerma PLC (LON:IDP), Mark Ward, Has Just Spent UK£270k Buying 22% More Shares

October 29, 2020 | lse.co.uk

Ishr Msci Eur A Regulatory News

October 29, 2020 | lse.co.uk

Xtr P Rhod Etc Regulatory News

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Specialty Retail
Sub-Industry: N/A
Sector: Consumer Cyclical
Current Symbol: LON:IDP
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.innovaderma.com
Phone: 61 3 9863 8030
Fax: N/A
Employees: 38
Year Founded: N/A

Sales & Book Value

Annual Sales: £9.82 million
Price / Sales: 0.83
Cash Flow: GBX 5.36 per share
Price / Cash Flow: 5.41
Book Value: GBX 7.90 per share
Price / Book: 3.67

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 55.52
Current Ratio: 1.93
Quick Ratio: 1.04

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 28,058,000
Free Float: N/A
Market Cap: £8.14 million
Optionable: Not Optionable

Company Calendar

Last Earnings: 9/30/2020
Today: 5/21/2022

MarketRank^™

Overall MarketRank^™

0.91 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for InnovaDerma.

4.5 Community Rank

Outperform Votes
InnovaDerma has received 156 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
InnovaDerma has received 76 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
InnovaDerma has received 67.24% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about InnovaDerma and other stocks. Vote “Outperform” if you believe IDP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IDP will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
InnovaDerma does not currently pay a dividend.
Dividend Growth
InnovaDerma does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, InnovaDerma insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of InnovaDerma is -3.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of InnovaDerma is -3.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
InnovaDerma has a P/B Ratio of 3.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

InnovaDerma (LON:IDP) Frequently Asked Questions

How were InnovaDerma's earnings last quarter?: InnovaDerma PLC (LON:IDP) announced its earnings results on Wednesday, September, 30th. The company reported ($2.00) earnings per share for the quarter, missing analysts' consensus estimates of $9.50 by $11.50.
View InnovaDerma's earnings history.
Who are InnovaDerma's key executives?: InnovaDerma's management team includes the following people:
Mr. Blake G. Hughes, CEO & Exec. Director
Mr. Andrew Dunderdale, Group Fin. Director & Exec. Director
Mr. Warren Dockary, Group Financial Controller
Who are some of InnovaDerma's key competitors?: Some companies that are related to InnovaDerma include QUIZ (QUIZ), Koovs (KOOV), Ceconomy (CEC1), MySale Group (MYSL), LXRandCo (LXR), Rocky Mountain Liquor (RUM), The Stanley Gibbons Group (SGI), Conduity Capital Plc (NTLG.L) (NTLG), Alcanna (LQSIF), ASOS (ASOMF), Baby Bunting Group (BBN), Beacon Lighting Group (BLX), Berkley Renewables (BKS), Bluestem Group (BGRP) and Canadian Tire (CDNAF).
View all of IDP's competitors.
What other stocks do shareholders of InnovaDerma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other InnovaDerma investors own include Sol-Gel Technologies (SLGL), Synovus Financial (SNV), Venator Materials (VNTR), BJ's Restaurants (BJRI), Christopher & Banks (CBK), Cidara Therapeutics (CDTX), eHealth (EHTH), Teledyne FLIR (FLIR), Imperial Brands (IMB) and ImmunoGen (IMGN).
What is InnovaDerma's stock symbol?: InnovaDerma trades on the London Stock Exchange (LON) under the ticker symbol "IDP."
How do I buy shares of InnovaDerma?: Shares of IDP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is InnovaDerma's stock price today?: One share of IDP stock can currently be purchased for approximately GBX 29.
How much money does InnovaDerma make?: InnovaDerma has a market capitalization of £8.14 million and generates £9.82 million in revenue each year.
How many employees does InnovaDerma have?: InnovaDerma employs 38 workers across the globe.
What is InnovaDerma's official website?: The official website for InnovaDerma is www.innovaderma.com.
How can I contact InnovaDerma?: The company can be reached via phone at 61 3 9863 8030.

This page was last updated on 5/22/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.